Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cells
Jerry H. Houl, Rozita Bagheri‐Yarmand, Muthusamy Kunnimalaiyaan, Paola Miranda Mendez, Joseph L. Kidd, Ali Dadbin, Andrea Ruiz-Jurado, Parag A Parekh, Ying C. Henderson, Nikhil S. Chari, Aatish Thennavan, Reid Trenton Powell, CLIFFORD C. STEPHAN, Xiao Ling Zhao, Anastasios Maniakas, , Marie-Claude C. Hofmann
This study identifies a link between the ETV5/p38 signaling axis and aggressive thyroid cancers, showing that combining p38 inhibitors with BRAF inhibitors improves treatment outcomes.
Molecular Cancer Therapeutics · Dec 2, 2025Peer-reviewedCancer Biology